Ali Saffaei to Prospective Studies
This is a "connection" page, showing publications Ali Saffaei has written about Prospective Studies.
Connection Strength
0.018
-
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869.
Score: 0.009
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.009